Behavioural interventions for enhancing life participation in behavioural variant frontotemporal dementia and primary progressive aphasia
- PMID: 23611353
- PMCID: PMC3659798
- DOI: 10.3109/09540261.2012.751017
Behavioural interventions for enhancing life participation in behavioural variant frontotemporal dementia and primary progressive aphasia
Abstract
Primary progressive aphasia (PPA) and behavioural-variant frontotemporal dementia (bvFTD) are clinical syndromes under the umbrella term 'frontotemporal dementia' (FTD) and are caused by a neurodegenerative disease with an onset most typically in the productive years of adulthood. The cognitive and behavioural impairments associated with FTD interfere with successful engagement in typical life roles, such as parenting, working, and maintenance of interpersonal relationships. There are currently no treatments to stop or slow the degenerative process and there are only very limited medication options for the management of the cognitive-behavioural symptoms. However, alternative, non-pharmacological interventions may offer significant benefit to the quality of life of the diagnosed individual. The goal of this paper is to provide an overview of the approaches available through neurorehabilitation and community-based services that facilitate successful engagement in life activities and promote optimal quality of life for the individuals and families living with FTD. It is hoped that as medical providers become more familiar with behavioural interventions, referrals for services will increase thereby allowing individuals with FTD and their caregivers to learn ways to adapt, adjust, and participate in life to the fullest despite the impairments from this progressive disease.
Similar articles
-
Progression of behavioural disturbances in frontotemporal dementia: a longitudinal observational study.Eur J Neurol. 2020 Feb;27(2):265-272. doi: 10.1111/ene.14071. Epub 2019 Sep 18. Eur J Neurol. 2020. PMID: 31448481
-
Generalized and symptom-specific insight in behavioral variant frontotemporal dementia and primary progressive aphasia.J Neuropsychiatry Clin Neurosci. 2009 Summer;21(3):299-306. doi: 10.1176/jnp.2009.21.3.299. J Neuropsychiatry Clin Neurosci. 2009. PMID: 19776310 Free PMC article.
-
Caregiver burden in patients with behavioural variant frontotemporal dementia and non-fluent variant and semantic variant primary progressive aphasia.J Neural Transm (Vienna). 2021 Oct;128(10):1623-1634. doi: 10.1007/s00702-021-02378-0. Epub 2021 Jul 19. J Neural Transm (Vienna). 2021. PMID: 34282470 Free PMC article.
-
[Frontotemporal dementias].Nervenarzt. 2013 Jan;84(1):20-32. doi: 10.1007/s00115-012-3477-x. Nervenarzt. 2013. PMID: 22366755 Review. German.
-
What is frontotemporal dementia?Maturitas. 2014 Oct;79(2):216-9. doi: 10.1016/j.maturitas.2014.07.001. Epub 2014 Jul 3. Maturitas. 2014. PMID: 25059437 Review.
Cited by
-
The Media Coverage of Bruce Willis Reveals Unfamiliarity With Frontotemporal Degeneration.Innov Aging. 2023 Oct 26;7(9):igad125. doi: 10.1093/geroni/igad125. eCollection 2023. Innov Aging. 2023. PMID: 38046892 Free PMC article.
-
'Like going into a chocolate shop, blindfolded': What do people with primary progressive aphasia want from speech and language therapy?Int J Lang Commun Disord. 2023 May;58(3):737-755. doi: 10.1111/1460-6984.12818. Epub 2022 Nov 30. Int J Lang Commun Disord. 2023. PMID: 36448629 Free PMC article.
-
Communication Bridge™-2 (CB2): an NIH Stage 2 randomized control trial of a speech-language intervention for communication impairments in individuals with mild to moderate primary progressive aphasia.Trials. 2022 Jun 13;23(1):487. doi: 10.1186/s13063-022-06162-7. Trials. 2022. PMID: 35698099 Free PMC article. Clinical Trial.
-
Frontotemporal Pathology in Motor Neuron Disease Phenotypes: Insights From Neuroimaging.Front Neurol. 2021 Aug 16;12:723450. doi: 10.3389/fneur.2021.723450. eCollection 2021. Front Neurol. 2021. PMID: 34484106 Free PMC article. Review.
-
Language training for oral and written naming impairment in primary progressive aphasia: a review.Transl Neurodegener. 2021 Jul 16;10(1):24. doi: 10.1186/s40035-021-00248-z. Transl Neurodegener. 2021. PMID: 34266501 Free PMC article. Review.
References
-
- Beeson PM, King RM, Bonakdarpour B, Henry ML, Cho H, Rapcsak SZ. Positive effects of language treatment for the logopenic variant of primary progressive aphasia. [Case Reports Research Support, N.I.H., Extramural]. Journal of molecular neuroscience : MN. 2011;45(3):724–736. doi: 10.1007/s12031-011-9579-2. - PMC - PubMed
-
- Buchanan JA, Christenson A, Houlihan D, Ostrom C. The role of behavior analysis in the rehabilitation of persons with dementia. [Review]. Behavior therapy. 2011;42(1):9–21. doi: 10.1016/j.beth.2010.01.003. - PubMed
-
- Croot K, Nickels L, Laurence F, Manning M. Impairment- and activity/participation-directed interventions in progressive language impairment: Clinical and theoretical issues. Aphasiology. 2009;23(2):125–160. doi: 10.1080/02687030801943179.
-
- Davison TE, Hudgson C, McCabe MP, George K, Buchanan G. An individualized psychosocial approach for “treatment resistant” behavioral symptoms of dementia among aged care residents. [Clinical Trial Comparative Study]. International psychogeriatrics / IPA. 2007;19(5):859–873. doi: 10.1017/S1041610206004224. - PubMed
Publication types
MeSH terms
Grants and funding
- P30 AG013854/AG/NIA NIH HHS/United States
- R01 NS047691/NS/NINDS NIH HHS/United States
- KL2 TR000107/TR/NCATS NIH HHS/United States
- 5KL2RR025740/RR/NCRR NIH HHS/United States
- DC008552/DC/NIDCD NIH HHS/United States
- R01NS047691-05A2/NS/NINDS NIH HHS/United States
- KL2 RR025740/RR/NCRR NIH HHS/United States
- R01 DC008552/DC/NIDCD NIH HHS/United States
- 1R01NS075075-01A1/NS/NINDS NIH HHS/United States
- R01 NS075075/NS/NINDS NIH HHS/United States
- AG13854/AG/NIA NIH HHS/United States
- 8KL2TR000107/TR/NCATS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
